Phase II: sildenafil citrate tablet produced by Viagra Pfizer Inc.

2 trials

Sponsors

Phase I Clinical laboratory, Xiangya Hospital, Central South University

Conditions

Pharmacokinetics and bioequivalence

Phase 1

A single dose, randomized, open-label bioequivalence study of sildenafil citrate tablets (specification 50mg) in Chinese healthy male volunteers

Active, not recruitingChiCTR-IIR-16008161

Phase I Clinical laboratory, Xiangya Hospital, Central South UniversityPharmacokinetics and bioequivalence

Start: 2016-04-01Updated: 2017-04-18

A randomized, open-label trial for bioequivalence of sildenafil citrate tablets (specification 100mg) in Chinese healthy male volunteers

Active, not recruitingChiCTR1800017967

Phase I Clinical laboratory, Xiangya Hospital, Central South UniversityPharmacokinetics and bioequivalence

Start: 2018-09-01Updated: 2018-08-27